Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionIgG receptor activity

FCGR2C FCGR2B

3.15e-057252GO:0019770
GeneOntologyMolecularFunctionIgG binding

FCGR2C FCGR2B

8.22e-0511252GO:0019864
GeneOntologyMolecularFunctionimmunoglobulin receptor activity

FCGR2C FCGR2B

1.36e-0414252GO:0019763
GeneOntologyMolecularFunctionimmunoglobulin binding

FCGR2C FCGR2B

9.24e-0436252GO:0019865
GeneOntologyMolecularFunctiontransmembrane transporter activity

LRRC55 MFSD14A BEST1 CYB561A3 SLC34A1 SLC14A2

2.82e-031180256GO:0022857
GeneOntologyMolecularFunctiontransporter activity

LRRC55 MFSD14A BEST1 CYB561A3 SLC34A1 SLC14A2

4.37e-031289256GO:0005215
GeneOntologyBiologicalProcesspositive regulation of humoral immune response

KLK5 HLA-DMA FCGR2B

6.25e-0630253GO:0002922
GeneOntologyBiologicalProcessregulation of humoral immune response

KLK5 HLA-DMA FCGR2B

5.14e-0560253GO:0002920
GeneOntologyBiologicalProcessantibody-dependent cellular cytotoxicity

FCGR2C FCGR2B

1.09e-0413252GO:0001788
GeneOntologyBiologicalProcesstype IIa hypersensitivity

FCGR2C FCGR2B

1.47e-0415252GO:0001794
GeneOntologyBiologicalProcesstype II hypersensitivity

FCGR2C FCGR2B

1.47e-0415252GO:0002445
GeneOntologyBiologicalProcessresponse to vitamin A

EPO SLC34A1

1.90e-0417252GO:0033189
GeneOntologyBiologicalProcessregulation of immune response

XBP1 FCGR2C KLK5 GBP4 HLA-DMA FCGR2B ALOX15

2.28e-041085257GO:0050776
GeneOntologyBiologicalProcessresponse to endoplasmic reticulum stress

XBP1 RNF103 FCGR2B ALOX15

4.09e-04295254GO:0034976
GeneOntologyBiologicalProcesshypersensitivity

FCGR2C FCGR2B

4.16e-0425252GO:0002524
GeneOntologyBiologicalProcessnegative regulation of myeloid cell apoptotic process

EPO FCGR2B

4.86e-0427252GO:0033033
GeneOntologyBiologicalProcessregulation of phagocytosis

FCGR2C FCGR2B ALOX15

5.80e-04136253GO:0050764
GeneOntologyBiologicalProcessacute inflammatory response

EPO FCGR2C FCGR2B

6.71e-04143253GO:0002526
GeneOntologyBiologicalProcessantigen processing and presentation of exogenous peptide antigen via MHC class II

HLA-DMA FCGR2B

6.84e-0432252GO:0019886
GeneOntologyBiologicalProcessantigen processing and presentation of peptide antigen via MHC class II

HLA-DMA FCGR2B

8.66e-0436252GO:0002495
GeneOntologyBiologicalProcessregulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway

XBP1 FCGR2B

9.15e-0437252GO:1902235
GeneOntologyBiologicalProcessantigen processing and presentation of peptide or polysaccharide antigen via MHC class II

HLA-DMA FCGR2B

9.65e-0438252GO:0002504
GeneOntologyBiologicalProcessmature B cell differentiation involved in immune response

XBP1 FCGR2B

9.65e-0438252GO:0002313
GeneOntologyBiologicalProcessFc-gamma receptor signaling pathway

FCGR2C FCGR2B

1.02e-0339252GO:0038094
GeneOntologyBiologicalProcesspositive regulation of cell-cell adhesion

XBP1 EPO HLA-DMA ALOX15

1.15e-03389254GO:0022409
GeneOntologyBiologicalProcessacute inflammatory response to antigenic stimulus

FCGR2C FCGR2B

1.18e-0342252GO:0002438
GeneOntologyBiologicalProcessregulation of myeloid cell apoptotic process

EPO FCGR2B

1.18e-0342252GO:0033032
DomainIg-like_fold

PLXNA4 ILDR1 HLA-DMA FCGR2B

1.01e-02706234IPR013783
DomainIG_LIKE

ILDR1 HLA-DMA FCGR2B

2.16e-02491233PS50835
DomainImmunoglobulin

HLA-DMA FCGR2B

2.26e-02190232IPR013151
Domainig

HLA-DMA FCGR2B

2.26e-02190232PF00047
DomainIg-like_dom

ILDR1 HLA-DMA FCGR2B

2.30e-02503233IPR007110
Pubmed

Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium.

FCGR2C FCGR2B

4.96e-0722522531080
Pubmed

Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene.

FCGR2C FCGR2B

4.96e-0722529516136
Pubmed

Functional Fcgamma receptor polymorphisms are associated with human allergy.

FCGR2C FCGR2B

1.49e-06325224586589
Pubmed

Genomic pathology of SLE-associated copy-number variation at the FCGR2C/FCGR3B/FCGR2B locus.

FCGR2C FCGR2B

1.49e-06325223261299
Pubmed

Nonallelic homologous recombination of the FCGR2/3 locus results in copy number variation and novel chimeric FCGR2 genes with aberrant functional expression.

FCGR2C FCGR2B

1.49e-06325226133275
Pubmed

Bone Marrow Endothelial Cells Take Up Blood-Borne Immune Complexes via Fcγ Receptor IIb2 in an Erythropoietin-Dependent Manner.

EPO FCGR2B

4.95e-06525232907997
Pubmed

SNPs of Fc-gamma receptor genes and chronic periodontitis.

FCGR2C FCGR2B

4.95e-06525220439936
Pubmed

Copy number, linkage disequilibrium and disease association in the FCGR locus.

FCGR2C FCGR2B

4.95e-06525220508037
Pubmed

Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation.

FCGR2B ALOX15

4.95e-06525225100742
Pubmed

Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B.

FCGR2C FCGR2B

4.95e-06525219309690
Pubmed

Activation of Hypoxia Signaling in Stromal Progenitors Impairs Kidney Development.

EPO SLC34A1 SLC14A2

5.21e-064725328527294
Pubmed

Trophoblasts regulate the placental hematopoietic niche through PDGF-B signaling.

EPO FCGR2B

1.14e-042225222387002
Pubmed

Hypoxia-inducible factor prolyl-4-hydroxylation in FOXD1 lineage cells is essential for normal kidney development.

EPO SLC34A1

1.85e-042825228847650
Pubmed

New genetic associations detected in a host response study to hepatitis B vaccine.

EPO FCGR2C GBP4 HLA-DMA FCGR2B

2.64e-0482425520237496
Pubmed

The trafficking protein Tmed2/p24beta(1) is required for morphogenesis of the mouse embryo and placenta.

XBP1 KNTC1

4.61e-044425220178780
Pubmed

LuTHy: a double-readout bioluminescence-based two-hybrid technology for quantitative mapping of protein-protein interactions in mammalian cells.

EPO RMI1 BEST1

5.11e-0421925329997244
Cytoband7q22

EPO MUC3A

1.98e-04382527q22
CytobandEnsembl 112 genes in cytogenetic band chr11q12

LRRC55 BEST1 CYB561A3

8.56e-04345253chr11q12
CytobandEnsembl 112 genes in cytogenetic band chr7q22

EPO MUC3A

6.32e-03219252chr7q22
CytobandEnsembl 112 genes in cytogenetic band chr1q23

FCGR2C FCGR2B

6.72e-03226252chr1q23
ToppCelldroplet-Bladder-nan-3m-Hematologic-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLXNA4 HLA-DMA FCGR2B ALOX15

1.46e-06151254a7b1a60d68f0ed17022fe4c97af64f9f08d39fa3
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FCGR2C ILDR1 HLA-DMA FCGR2B

1.88e-061612541e9b833a20f5fb936a71cab24c87ff24bc3c8942
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLXNA4 CYB561A3 HLA-DMA FCGR2B

2.68e-06176254d687e6c3f9043f2574d072f815b8c2258f9dc7b5
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLXNA4 CYB561A3 HLA-DMA FCGR2B

2.68e-061762544f37854124d77ee64dcb40fd491eaed2ba389891
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLXNA4 CYB561A3 HLA-DMA FCGR2B

2.68e-061762540afba8707b847e5bdf6f38fe4379967631fe2240
ToppCelldroplet-Lung-LUNG-1m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ILDR1 CYB561A3 HLA-DMA SLC34A1

2.81e-061782549b932b677ae05ac6e12cd6ce97789f8c10e4790b
ToppCellIIF-Lymphocyte-B-B_memory|IIF / Disease, Lineage and Cell Type

ILDR1 CYB561A3 HLA-DMA FCGR2B

3.27e-06185254c0eeab45c4ddefe107690a4ba8868fed2962c730
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ILDR1 CYB561A3 HLA-DMA FCGR2B

3.41e-0618725443f81863063509337bd56a67010c62fb51109bd5
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_memory|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)

ILDR1 CYB561A3 HLA-DMA FCGR2B

3.41e-06187254ea56cfca919a09db852b7ee5e42323f822962465
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_memory|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ILDR1 CYB561A3 HLA-DMA FCGR2B

3.49e-06188254b6ae707b033a17c75ca81f9194631ead1b63d170
ToppCellremission-B_memory|remission / disease stage, cell group and cell class

ILDR1 CYB561A3 HLA-DMA FCGR2B

3.56e-06189254a7b434a5d2cc7c3952cb8f16d11219b691c6c2b6
ToppCellCOVID-19_Convalescent-Lymphoid_B-B_memory|COVID-19_Convalescent / Disease group, lineage and cell class

ILDR1 CYB561A3 HLA-DMA FCGR2B

3.71e-061912544a853cd2434b0f5b18e1f853c37515845046c88b
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FCGR2C BEST1 HLA-DMA FCGR2B

3.71e-061912547bad04f8afa949ea952c5c0d71eec43271ade680
ToppCellB_cells-Activate_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

ILDR1 CYB561A3 HLA-DMA FCGR2B

3.87e-06193254b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

ILDR1 CYB561A3 HLA-DMA FCGR2B

4.03e-0619525451e6cfecd66a874673d0b79a295489a358bddfd5
ToppCellILEUM-inflamed-(5)_Plasma-(5)_IgG_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

XBP1 BEST1 HLA-DMA FCGR2B

4.20e-061972546b0941883e40bd82c65659b97a4752e8e32ac190
ToppCellMS-IIF-Lymphocyte-B-B_memory|IIF / Disease, condition lineage and cell class

ILDR1 CYB561A3 HLA-DMA FCGR2B

4.28e-06198254ae6f1d3ca7d7aa6f6f45b6b51aa8a967cadde017
ToppCellmild-B_memory|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ILDR1 CYB561A3 HLA-DMA FCGR2B

4.37e-06199254e6ac9a0959b0de2c6a99298feb7715aa80ade1dd
ToppCellCOVID-19-COVID-19_Convalescent-Lymphocyte-B-B_memory|COVID-19_Convalescent / Disease, condition lineage and cell class

ILDR1 CYB561A3 HLA-DMA FCGR2B

4.37e-061992545bbda86486910d053ca51b9caee487d78f6462cb
ToppCellsevere-B_memory|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ILDR1 CYB561A3 HLA-DMA FCGR2B

4.37e-061992546d3436dd65d525aaa23ec02672005380f21c4d0f
ToppCellmild-B_memory|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ILDR1 CYB561A3 HLA-DMA FCGR2B

4.37e-06199254025bb65629d9e20c374e8f1ba08c36d1bb569190
ToppCellMS-Multiple_Sclerosis-Lymphocyte-B-B_memory|Multiple_Sclerosis / Disease, condition lineage and cell class

ILDR1 CYB561A3 HLA-DMA FCGR2B

4.37e-06199254ae2979c0d2711580863d3b751f6ff1e3abdfd90e
ToppCellTCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-5|TCGA-Kidney / Sample_Type by Project: Shred V9

LRRC55 KLK5 SLC34A1

9.97e-0675253c1ab2eb49eebfdb10dc32c935804e8771260ca6c
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYB561A3 HLA-DMA FCGR2B

7.92e-051502534bdcdce40f54580c7a4e1416b468e657ba8874fc
ToppCell390C-Myeloid-Macrophage-SPP1+_Macrophage_3|390C / Donor, Lineage, Cell class and subclass (all cells)

BEST1 FCGR2B SLC14A2

8.23e-05152253f717aae4882e9b67e5e40f4ef5b0d35f74a89165
ToppCellPND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HLA-DMA FCGR2B ALOX15

8.23e-05152253b2e29fbda6b5f2d87cfc05423caf9cbf3b04ac65
ToppCelldroplet-Fat-SCAT-30m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

C20orf173 HLA-DMA FCGR2B

8.56e-0515425373de626b210ec5482ba89a65e784c1e77ff2894e
ToppCelldroplet-Fat-SCAT-30m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

C20orf173 HLA-DMA FCGR2B

8.56e-0515425356fe9953e58f71626d3ddf63d340ed35dfc4ce9f
ToppCellfacs-MAT-Fat-24m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HLA-DMA FCGR2B ALOX15

8.72e-05155253d0c1608f8f6b6f4174e51d610501c707cba5e015
ToppCellfacs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ILDR1 HLA-DMA FCGR2B

9.41e-05159253656aa20706bdba81bbcc3e68e6058215b92b8802
ToppCelldroplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ILDR1 HLA-DMA SLC34A1

9.41e-0515925374655c22e9fdd88e3052b9dfb954c8fb678bd2d8
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYB561A3 HLA-DMA FCGR2B

9.58e-051602538396afbc7d919ba190863d50aa0ef8b9942a9866
ToppCellTransplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

DNHD1 GBP4 ALOX15

9.58e-051602536de505bfe1fbbe984718740a9cf43d0e02ff452e
ToppCelldroplet-Fat-SCAT-30m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

C20orf173 HLA-DMA FCGR2B

9.58e-0516025361eefe84c8e30d8a3812f5b48d26ed01739aa1ce
ToppCellHippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Hippocampus / BrainAtlas - Mouse McCarroll V32

LRRC55 BEST1 ILDR1

9.76e-0516125366554f59eaea4ba55a6c6724f9368e24e99c91e9
ToppCellPND07-28-samps-Myeloid-Macrophage|PND07-28-samps / Age Group, Lineage, Cell class and subclass

CYB561A3 HLA-DMA FCGR2B

9.94e-051622537c73fe8388af370461e04097cf145cbc9847285b
ToppCellE18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass

BEST1 HLA-DMA FCGR2B

9.94e-0516225360d3fe1f5cec4285b8774ff078ebcc6bfaec26ed
ToppCellE18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass

BEST1 HLA-DMA FCGR2B

9.94e-0516225318e4a807e25f754a69e9eaaddfde40f8de9b8512
ToppCellE18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass

BEST1 HLA-DMA FCGR2B

9.94e-051622530970e4eda60e3f015335e2726e6d565fb2f43372
ToppCell3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_memory|bone_marrow / Manually curated celltypes from each tissue

CYB561A3 HLA-DMA FCGR2B

1.01e-0416325330f5c93c4e170304d701b5231f0d545f404066f7
ToppCelldroplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CYB561A3 HLA-DMA SLC34A1

1.03e-04164253cfe07a1ebed8aecb08d0476db71fe314998d54aa
ToppCelldroplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CYB561A3 HLA-DMA SLC34A1

1.03e-041642536d331e74efecb4733d87653f86cd67247be05025
ToppCelldroplet-Lung-nan-18m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYB561A3 HLA-DMA SLC34A1

1.07e-041662533e3e9296e6919a38602e417a6606c046af3bd101
ToppCelldroplet-Lung-LUNG-1m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HLA-DMA FCGR2B SLC34A1

1.07e-04166253c215c4aede38d355d35fd26cd7ef2c19efecd0e6
ToppCelldroplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

HLA-DMA FCGR2B SLC34A1

1.11e-0416825399148986aa5628f67d85258c171b254be77a071c
ToppCelldroplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HLA-DMA FCGR2B SLC34A1

1.13e-04169253735655e75511c5c41aca667909e8bb52a0ad7fc6
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FCGR2C HLA-DMA FCGR2B

1.13e-04169253c100a91be9b94bd433a3b172f4a1bfb9d2393003
ToppCelldroplet-Pancreas-Endocrine-21m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HLA-DMA FCGR2B SLC34A1

1.15e-041702536086d658a52a1961a1e293cbc3703ae8d309cd11
ToppCell10x5'-Liver-Lymphocytic_B-ABC_aged-B_memory|Liver / Manually curated celltypes from each tissue

CYB561A3 HLA-DMA FCGR2B

1.17e-04171253eb47f4a09a630ed14a0898377039ed50ef7cc292
ToppCelldroplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

HLA-DMA FCGR2B SLC34A1

1.17e-0417125338a05b5ec8ef8f09a2399994c6b4b9a707918ec1
ToppCellCOVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass

PLXNA4 CYB561A3 HLA-DMA

1.17e-04171253779c951d274ecbd1d546ac425d6c8e718623be5a
ToppCellCOVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass

PLXNA4 CYB561A3 HLA-DMA

1.17e-04171253debbb071d260639b16269c94d172766908325c58
ToppCellICU-NoSEP-Lymphocyte-B-B_intermediate|ICU-NoSEP / Disease, Lineage and Cell Type

CYB561A3 HLA-DMA FCGR2B

1.17e-04171253c6b8578577aef4fe79c1a8ca778a068052f2c9d4
ToppCelldroplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MFSD14A BEST1 CYB561A3

1.19e-0417225324ecfda5e43e28f190089770cd2eae5bf2ed292b
ToppCelldroplet-Limb_Muscle-nan-21m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HLA-DMA FCGR2B SLC34A1

1.19e-0417225362734d231290ca725276dc62faa2ac87bd1b37b8
ToppCell3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CYB561A3 HLA-DMA FCGR2B

1.19e-041722530bcb960c5ab0d3cbbdf6235b6f28327ea60ba3e3
ToppCelldroplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MFSD14A BEST1 CYB561A3

1.19e-04172253db5a31cafce4346fe459d7f35210823fd7004439
ToppCelldroplet-Lung-nan-21m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLXNA4 HLA-DMA FCGR2B

1.21e-041732531cff815536f620e32b9805666e1aa711462c2d25
ToppCell3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CYB561A3 HLA-DMA FCGR2B

1.21e-0417325367c342295b8a06ce38e081ba74478c568917a396
ToppCelldroplet-Lung-nan-21m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLXNA4 HLA-DMA FCGR2B

1.21e-0417325331ea04e65876c42b90245d280f0b6439bfffbace
ToppCelldroplet-Tongue-Unstain-18m-Myeloid|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BEST1 HLA-DMA FCGR2B

1.23e-04174253f2eb0199f59e1e2f46da344c05289876bd254fa3
ToppCelldroplet-Tongue-Unstain-18m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BEST1 HLA-DMA FCGR2B

1.23e-041742539019011eb8d9b7a95804fc11434f0fd42418103a
ToppCelldroplet-Tongue-Unstain-18m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BEST1 HLA-DMA FCGR2B

1.23e-04174253deafbd0c2523afe09cc42f8c7b33945f3f5c00b4
ToppCelldroplet-Lung-nan-21m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HLA-DMA FCGR2B ALOX15

1.23e-04174253763ca53339d9e236da8463f2a9d1bd39d4385d75
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYB561A3 HLA-DMA FCGR2B

1.25e-041752531b3510e9078eec7cfc5805043e435e9e5e0f0877
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYB561A3 HLA-DMA FCGR2B

1.25e-04175253eaec7fda07a9537d067ca13b607a8ab201caa7c4
ToppCellIIF-Lymphocyte-B-B_intermediate|IIF / Disease, Lineage and Cell Type

CYB561A3 HLA-DMA FCGR2B

1.25e-04175253327f8ee3669c3fc5ba50abc3b4f3e068637fd8d8
ToppCell(03)_Secretory|World / shred by cell type and Timepoint

XBP1 ILDR1 ALOX15

1.27e-04176253cb7b1945788196ca79007f0768b6576ec885a0e5
ToppCellfacs-Brain_Non-Myeloid-Striatum_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ILDR1 HLA-DMA FCGR2B

1.29e-0417725356fe389ffab73e3bc64f837b152d5907e3517a91
ToppCell5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Paneth|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

XBP1 ILDR1 SLC14A2

1.29e-041772533743a7d69db9ac4cad70eb531f7075849f34f16b
ToppCellB_cell_maturation-CD34+_pre-plamsa|World / Lineage and Cell class

XBP1 GBP4 HLA-DMA

1.29e-041772533ff06100deee9bee852a52078666999a9f7beaf1
ToppCellfacs-Brain_Non-Myeloid-Striatum_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ILDR1 HLA-DMA FCGR2B

1.29e-04177253201b0a8e6402a18aff0bb7c14f2bdd34fdf0db32
ToppCellfacs-Brain_Non-Myeloid-Striatum_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ILDR1 HLA-DMA FCGR2B

1.29e-041772532a63288d09efd217b277aeecf957811a095f56e7
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYB561A3 HLA-DMA FCGR2B

1.31e-04178253812e261d9cbdc74fafe3c5c3422151c1cfacb22d
ToppCellwk_20-22-Hematologic_Lymphocytic-B-Late_pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

XBP1 GBP4 HLA-DMA

1.31e-041782534e28a8bd5a603518bfe993712ab785308691b5ff
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYB561A3 HLA-DMA FCGR2B

1.31e-041782535d41fede13c8e64b6fdaf2155f1eb72bcfc32fdb
ToppCellLeuk-UTI-Lymphocyte-B-B_intermediate|Leuk-UTI / Disease, Lineage and Cell Type

CYB561A3 HLA-DMA FCGR2B

1.34e-0417925301933f6fa94d7032ed403a6cae6985cafa820043
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-B_memory-0|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ILDR1 HLA-DMA FCGR2B

1.34e-04179253fce1ba53815145f6248d4e90aedca3dad84e33e4
ToppCelldroplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CYB561A3 HLA-DMA SLC34A1

1.36e-04180253d8135f73a89b97168f2048258f4648e23536ece4
ToppCelldroplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CYB561A3 HLA-DMA SLC34A1

1.36e-04180253c12c1cc206f7e63e5722471bd3eb84caddb84129
ToppCellfacs-MAT-Fat-24m-Lymphocytic-B_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYB561A3 HLA-DMA FCGR2B

1.36e-04180253711719219bcbafdd505790eda895e7a33f21bed2
ToppCell3'_v3-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue

PLXNA4 CYB561A3 HLA-DMA

1.38e-0418125366d890a105f955dca91d6e5e6c730d1a68ee9233
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYB561A3 HLA-DMA FCGR2B

1.38e-041812536df40f86c569b6ecfc3137a68d1355b012dbf6bf
ToppCell3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CYB561A3 HLA-DMA FCGR2B

1.38e-0418125351836cdc66e42f04ed6a3c167cd6a3a67428c9f7
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FCGR2C HLA-DMA FCGR2B

1.40e-0418225316186b7a0c33caa48631962381e3ab7e5d166163
ToppCellB_cells-Naive_B_cells_|World / Immune cells in Kidney/Urine in Lupus Nephritis

CYB561A3 HLA-DMA FCGR2B

1.40e-0418225363c3b63315276b66667d49fab09661ac320e7a36
ToppCellnormal-na-Lymphocytic_B-B_mem-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

CYB561A3 HLA-DMA FCGR2B

1.40e-04182253ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870
ToppCellremission-B_naive|World / disease stage, cell group and cell class

CYB561A3 HLA-DMA FCGR2B

1.40e-04182253cc1dfd2de35aee1a26f7efd78e108b60a3556ec5
ToppCelldroplet-Mammary_Gland-nan-21m-Lymphocytic-B_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYB561A3 HLA-DMA FCGR2B

1.40e-0418225397f393549c7718a32af55b2377801bfebb10cc52
ToppCellfacs-Thymus-Flowthrough-24m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYB561A3 HLA-DMA FCGR2B

1.43e-041832530513bb73552bfee609877d924fa97684200f595c
ToppCell10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CYB561A3 HLA-DMA FCGR2B

1.43e-04183253dbc7ec66da5930c2bf4e0405937b054e04c22a34
ToppCellfacs-Brain_Non-Myeloid-Striatum_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ILDR1 HLA-DMA FCGR2B

1.43e-04183253824ecda1219fb596a01bf5cfeee29a6daa462098
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_B-B_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CYB561A3 HLA-DMA FCGR2B

1.43e-041832536086a862ab35bc683af44c03ee14cbb08ab99945
ToppCellremission-B_naive|remission / disease stage, cell group and cell class

CYB561A3 HLA-DMA FCGR2B

1.43e-04183253280d55d67f1d44594206da2f3a332c9d799dbdf0
ToppCellfacs-Thymus-Flowthrough-24m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYB561A3 HLA-DMA FCGR2B

1.43e-0418325385b2335fa938a94e74251bd8d99de1bd21265ac9
ToppCell3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CYB561A3 HLA-DMA FCGR2B

1.43e-0418325332880e71adba1b63fa9ec8530a8d4e46cc277c3a
ToppCellfacs-Brain_Non-Myeloid-Striatum_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ILDR1 HLA-DMA FCGR2B

1.43e-0418325382b84ee065fb573688d59da97a327152a1ba294c
ToppCellfacs-Thymus-Flowthrough-24m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYB561A3 HLA-DMA FCGR2B

1.43e-041832536eeef55071ae25a61616df4fcfb2cea560aa7923
ToppCell3'_v3-blood-Lymphocytic_B-Memory_B_cells|blood / Manually curated celltypes from each tissue

ILDR1 HLA-DMA FCGR2B

1.43e-04183253e3a418b745d7f040adf47be9e1043b945cae47ed
ToppCelldroplet-Mammary_Gland-nan-21m-Lymphocytic-B_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYB561A3 HLA-DMA FCGR2B

1.43e-04183253e7038532a6e159bb3e383cdd9c44b3b7f21c0c01
DrugMDL 20,610

FCGR2C FCGR2B

1.16e-055252CID000128209
DrugTAN-1030A

FCGR2C FCGR2B

1.73e-056252CID009576886
DrugTAN-999

FCGR2C FCGR2B

2.42e-057252CID000130283
DrugAC1MHTIN

FCGR2C FCGR2B

2.42e-057252CID003011133
DrugIntravenous Immunoglobulin

FCGR2C FCGR2B

3.23e-058252DB00028
DrugAC1NSK5W

FCGR2C FCGR2B

4.15e-059252CID005311182
DrugPalivizumab

FCGR2C FCGR2B

5.18e-0510252DB00110
DrugDenny-Jaffe reagent

FCGR2C FCGR2B

5.18e-0510252CID003035979
DrugBevacizumab

FCGR2C FCGR2B

6.33e-0511252DB00112
DrugTositumomab

FCGR2C FCGR2B

6.33e-0511252DB00081
DrugAlemtuzumab

FCGR2C FCGR2B

6.33e-0511252DB00087
DrugEfalizumab

FCGR2C FCGR2B

6.33e-0511252DB00095
DrugAlefacept

FCGR2C FCGR2B

6.33e-0511252DB00092
DrugDaclizumab

FCGR2C FCGR2B

7.59e-0512252DB00111
DrugNatalizumab

FCGR2C FCGR2B

7.59e-0512252DB00108
DrugRituximab

FCGR2C FCGR2B

7.59e-0512252DB00073
DrugIbritumomab

FCGR2C FCGR2B

7.59e-0512252DB00078
DrugAdalimumab

FCGR2C FCGR2B

7.59e-0512252DB00051
DrugGemtuzumab ozogamicin

FCGR2C FCGR2B

7.59e-0512252DB00056
DrugCetuximab

FCGR2C FCGR2B

7.59e-0512252DB00002
DrugTrastuzumab

FCGR2C FCGR2B

8.96e-0513252DB00072
DrugBasiliximab

FCGR2C FCGR2B

8.96e-0513252DB00074
Drugtetrachloroethylene

EPO FCGR2C FCGR2B

9.43e-0581253CID000031373
DrugAbciximab

FCGR2C FCGR2B

1.04e-0414252DB00054
DrugEtanercept

FCGR2C FCGR2B

1.04e-0414252DB00005
DrugMuromonab

FCGR2C FCGR2B

1.20e-0415252DB00075
DrugAC1L9LSE

FCGR2C FCGR2B

1.38e-0416252CID000448272
Drug2cgx

FCGR2C FCGR2B

1.75e-0418252CID001548380
Drugimidazoquinoline

XBP1 FCGR2C FCGR2B

1.82e-04101253CID005351568
DrugR13-1

FCGR2C FCGR2B

1.96e-0419252CID000009666
DrugLoestrin

FCGR2C FCGR2B

2.40e-0421252CID000062925
Drug3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole

EPO ALOX15

2.40e-0421252ctd:C090937
Drugbutylated hydroxyanisole

XBP1 CYB561A3

2.64e-0422252CID000008456
DrugAC1Q5JRE

FCGR2C FCGR2B

2.64e-0422252CID000188349
Drughistamine

FCGR2C KLK5 FCGR2B MUC3A ALOX15

3.12e-04560255CID000000774
DrugAC1N2DGT

EPO ALOX15

4.94e-0430252CID004045015
Drugsalicylhydroxamic acid

EPO CYB561A3 ALOX15

5.36e-04146253CID000066644
Drugphosphomevalonate

HLA-DMA SLC14A2

5.99e-0433252CID000000476
DrugAC1L19O6

FCGR2C FCGR2B ALOX15

6.50e-04156253CID000025750
DrugApomab

FCGR2C FCGR2B

7.13e-0436252CID000072231
DrugDB02197

EPO SLC14A2

7.13e-0436252CID005288527
DrugAC1O3GBZ

KNTC1 EPO

7.13e-0436252CID006327751
Drugazetidine

XBP1 HLA-DMA

7.13e-0436252CID000010422
Drugcandesartan

EPO SLC34A1 SLC14A2

7.25e-04162253CID000002541
Drug2-Br

FCGR2C FCGR2B

8.37e-0439252CID000007244
Drugpyrazin

KNTC1 HLA-DMA

8.37e-0439252CID000009261
DrugNorepinephrine

XBP1 EPO SLC14A2

8.48e-04171253ctd:D009638
DrugAC1NS1CY

FCGR2C FCGR2B

8.80e-0440252CID005326941
DrugFR 4

FCGR2C FCGR2B

8.80e-0440252CID005288243
DrugS-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (2R)-2-[4-(2-methylpropyl)phenyl]propanethioate

FCGR2C FCGR2B

9.25e-0441252CID009854504
DrugAC1L9FUA

FCGR2C FCGR2B

1.02e-0343252CID000444168
DrugAC1L97QT

CYB561A3 HLA-DMA

1.02e-0343252CID000439641
Drugpropham

FCGR2C FCGR2B

1.06e-0344252CID000024685
Diseasehematocrit

XBP1 EPO FCGR2C ILDR1 FCGR2B SLC34A1 SLC14A2

8.23e-061011237EFO_0004348
Diseaseplexin-B2 measurement

FCGR2C FCGR2B

2.09e-059232EFO_0021867
Diseasemalaria (implicated_via_orthology)

FCGR2C FCGR2B

2.09e-059232DOID:12365 (implicated_via_orthology)
Diseasered blood cell density measurement

XBP1 EPO FCGR2C FCGR2B SLC34A1 SLC14A2

4.52e-05880236EFO_0007978
Diseaselow affinity immunoglobulin gamma Fc region receptor II-a measurement

FCGR2C FCGR2B

7.85e-0517232EFO_0021969
Diseaselow affinity immunoglobulin gamma Fc region receptor II-b measurement

FCGR2C FCGR2B

1.72e-0425232EFO_0021970
Diseasesystemic lupus erythematosus (implicated_via_orthology)

FCGR2C FCGR2B

5.15e-0443232DOID:9074 (implicated_via_orthology)
Diseaseserum albumin measurement

RMI1 FCGR2C FCGR2B SLC14A2

1.05e-03592234EFO_0004535
Diseasemean corpuscular hemoglobin concentration

XBP1 KNTC1 FCGR2B SLC34A1 RTTN

1.40e-031105235EFO_0004528
Diseasegut microbiome measurement, bone density

FCGR2C FCGR2B

1.68e-0378232EFO_0003923, EFO_0007874
Diseasesmoking behavior

PLXNA4 RMI1 SLC14A2

2.28e-03341233EFO_0004318
Diseasevital capacity

KNTC1 RMI1 BEST1 SLC34A1 SLC14A2

2.29e-031236235EFO_0004312

Protein segments in the cluster

PeptideGeneStartEntry
WADCKSPQPWGHMLL

FCGR2B

16

P31994
LEKLSLPHNMFWVPW

BEST1

171

O76090
WLVLDNCHLMPHWPK

DNHD1

4151

Q96M86
NPWVCGCTMEPLLKW

LRRC55

196

Q6ZSA7
WADCKSPQPWGHMLL

FCGR2C

16

P31995
MKAMPWNWTCLLSHL

PLXNA4

1

Q9HCM2
LLGLLWMLKASPWAT

MUC3A

6

Q02505
MAWPKLPAPWLLLCT

ILDR1

1

Q86SU0
WEPKWTKICSLHSLP

MT-ATP8

51

P03928
PPMAWLLAKCWVRSS

ALOX15

336

P16050
WDMLLEKWLCPSTKP

KNTC1

1816

P50748
KGIWMWCVPHLSKPN

GBP4

91

Q96PP9
PPWMWVLCALITALL

KLK5

6

Q9Y337
LWCWDLLHMKTSLPP

HAUS5

531

O94927
FTCAPIPLMKISPWW

MFSD14A

111

Q96MC6
WDFLPRWMHSLKPLD

SLC34A1

576

Q06495
LLQMLPLLWLLPHSW

HLA-DMA

11

P28067
MGVHECPAWLWLLLS

EPO

1

P01588
LPWASMWLRSLLKPI

CYB561A3

141

Q8NBI2
CPWPCLHSLWMEISP

C20orf173

16

Q96LM9
PDWLTWPADMLHCTE

RNF103

606

O00237
LVLMPWGPWHCHCKS

MENT

201

Q9BUN1
PVLHSLWPWILMDDS

RTTN

1951

Q86VV8
AAWHVKVPPMWLEAC

RMI1

16

Q9H9A7
LCQWGRHQPSWKPLM

XBP1

246

P17861
KWMVLASPWLILACC

PIGG

651

Q5H8A4
WWLLLPVIIMSMSCP

SLC14A2

666

Q15849